{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T23:56:12Z","timestamp":1780617372743,"version":"3.54.1"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"Supplement 1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,10]]},"abstract":"<jats:p>Changes in the colonic microbiota are critical to the pathogenesis of diverticular complications such as diverticulitis and peridiverticular abscesses. However, more subtle changes in microbiota composition may well be important to the more chronic manifestations of diverticulosis. Some studies have shown the presence of bacterial overgrowth in subgroups of patients with diverticular disease and recent studies, using molecular biology techniques, found an increase of proteobacteria and actinobacteria in patients with symptomatic uncomplicated diverticular disease (SUDD), compared with healthy controls. The use of probiotics to modulate intestinal microecology in SUDD appears therefore rational. Although several investigations evaluating the clinical efficacy of probiotics have been performed, no definitive results have yet been achieved, mainly due to the heterogeneity of the available studies. Most of the studies used probiotics in combination with poorly absorbed antimicrobials or anti-inflammatory drugs. In only 4 studies, there was a harm using probiotics alone, but only 1 was a placebo-controlled, double-blind trial. The analysis of the available evidence reveals a poor quality of the published studies, whose design was heterogeneous, with only 2 out of 11 trials being double-blind and randomized. Therefore, available data can only suggest a benefit of probiotics in SUDD, but do not allow any evidence-based definite conclusion. As a consequence, current guidelines state that there is insufficient evidence to recommend probiotics for symptom relief in patients with diverticular disease.<\/jats:p>","DOI":"10.1097\/mcg.0000000000000641","type":"journal-article","created":{"date-parts":[[2016,9,13]],"date-time":"2016-09-13T10:23:46Z","timestamp":1473762226000},"page":"S70-S73","source":"Crossref","is-referenced-by-count":17,"title":["Probiotics for the Treatment of Symptomatic Uncomplicated Diverticular Disease"],"prefix":"10.1097","volume":"50","author":[{"given":"Carmelo","family":"Scarpignato","sequence":"first","affiliation":[{"name":"Department of Clinical & Experimental Medicine, Clinical Pharmacology & Digestive Pathophysiology Unit, University of Parma"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Bertel\u00e9","sequence":"additional","affiliation":[{"name":"Department of Clinical & Experimental Medicine, Clinical Pharmacology & Digestive Pathophysiology Unit, University of Parma"},{"name":"Laboratory for GI Functional Investigations, Maggiore University Hospital, Parma"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Tursi","sequence":"additional","affiliation":[{"name":"Gastroenterology Service, ASL BAT, Andria, BT, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230913","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1038\/ajg.2012.194","article-title":"Diverticular disease as a chronic illness: evolving epidemiologic and clinical insights","volume":"107","author":"Strate","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"R2-20230913","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/bjs.4277","article-title":"Origin of symptoms in diverticular disease","volume":"90","author":"Simpson","year":"2003","journal-title":"Br J Surg"},{"key":"R3-20230913","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1365-2982.2011.01863.x","article-title":"Visceral hypersensitivity in symptomatic diverticular disease and the role of neuropeptides and low grade inflammation","volume":"24","author":"Humes","year":"2012","journal-title":"Neurogastroenterol Motil"},{"key":"R4-20230913","first-page":"127","article-title":"Gut microbiota, inflammation and symptomatic diverticular disease. New insights into an old and neglected disorder","volume":"19","author":"Quigley","year":"2010","journal-title":"J Gastrointestin Liver Dis"},{"key":"R5-20230913","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1503\/cmaj.120580","article-title":"Advances in the management of colonic diverticulitis","volume":"184","author":"Tursi","year":"2012","journal-title":"CMAJ"},{"key":"R6-20230913","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1365-2036.2007.03266.x","article-title":"Interaction between rifaximin and dietary fibre in patients with diverticular disease","volume":"25","author":"D\u2019Inc\u00e0","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"R7-20230913","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.3748\/wjg.v11.i18.2773","article-title":"Assessment of small intestinal bacterial overgrowth in uncomplicated acute diverticulitis of the colon","volume":"11","author":"Tursi","year":"2005","journal-title":"World J Gastroenterol"},{"key":"R8-20230913","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.3748\/wjg.v13.i29.3985","article-title":"Qualitative and quantitative analyses of the bifidobacterial microbiota in the colonic mucosa of patients with colorectal cancer, diverticulitis and inflammatory bowel disease","volume":"13","author":"Gueimonde","year":"2007","journal-title":"World J Gastroenterol"},{"issue":"suppl 1","key":"R9-20230913","first-page":"A60","article-title":"Gut microbiota molecular spectrum in healthy controls, diverticular disease, IBS and IBD patients: time for microbial marker of gastrointestinal disorders?","volume":"3","author":"Lopetuso","year":"2014","journal-title":"UEG J"},{"key":"R10-20230913","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/apt.13322","article-title":"Review article: the pathophysiology and medical management of diverticulosis and diverticular disease of the colon","volume":"42","author":"Tursi","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"R11-20230913","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nrgastro.2014.66","article-title":"Expert consensus document. The International Scientific Association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic","volume":"11","author":"Hill","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R12-20230913","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s12223-008-0023-0","article-title":"The protective potency of probiotic bacteria and their microbial products against enteric infections-review","volume":"53","author":"Koninkx","year":"2008","journal-title":"Folia Microbiol"},{"key":"R13-20230913","first-page":"76","article-title":"Probiotic-induced changes in the intestinal epithelium: implications in gastrointestinal disease","volume":"30","author":"Ramakrishna","year":"2009","journal-title":"Trop Gastroenterol"},{"key":"R14-20230913","first-page":"44","article-title":"Probiotic therapy of intestinal inflammation and infections","volume":"21","author":"Sartor","year":"2005","journal-title":"Curr Opin Gastroenterol"},{"key":"R15-20230913","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000335721","article-title":"Is it diverticular disease or is it irritable bowel syndrome?","volume":"30","author":"Spiller","year":"2012","journal-title":"Dig Dis"},{"key":"R16-20230913","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1038\/ajg.2014.367","article-title":"Editorial: new thoughts on the association between diverticulosis and irritable bowel syndrome","volume":"109","author":"Spiller","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"R17-20230913","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/ajg.2015.78","article-title":"Diverticular disease of the colon and irritable bowel syndrome: it is time to differentiate","volume":"110","author":"Tursi","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"R18-20230913","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1038\/ajg.2014.258","article-title":"Editorial: the importance of systematic reviews and u-analyses of probiotics and prebiotics","volume":"109","author":"Whelan","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"R19-20230913","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.3748\/wjg.14.2650","article-title":"Meta-analysis of probiotics for the treatment of irritable bowel syndrome","volume":"14","author":"McFarland","year":"2008","journal-title":"World J Gastroenterol"},{"key":"R20-20230913","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1471-230X-9-15","article-title":"A systematic review and meta-analysis: probiotics in the treatment of irritable bowel syndrome","volume":"9","author":"Hoveyda","year":"2009","journal-title":"BMC Gastroenterol"},{"key":"R21-20230913","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/gut.2008.167270","article-title":"The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review","volume":"59","author":"Moayyedi","year":"2010","journal-title":"Gut"},{"key":"R22-20230913","doi-asserted-by":"crossref","first-page":"e34938","DOI":"10.1371\/journal.pone.0034938","article-title":"A meta-analysis of probiotic efficacy for gastrointestinal diseases","volume":"7","author":"Ritchie","year":"2012","journal-title":"PLoS One"},{"key":"R23-20230913","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1038\/ajg.2014.202","article-title":"Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis","volume":"109","author":"Ford","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"R24-20230913","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.3748\/wjg.v21.i10.3072","article-title":"Effectiveness of probiotics in irritable bowel syndrome: updated systematic review with meta-analysis","volume":"21","author":"Didari","year":"2015","journal-title":"World J Gastroenterol"},{"key":"R25-20230913","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1177\/0884533608329230","article-title":"Probiotics and diverticular disease","volume":"24","author":"Sheth","year":"2009","journal-title":"Nutr Clin Pract"},{"key":"R26-20230913","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1111\/j.1440-1746.2010.06444.x","article-title":"Role of probiotics in management of diverticular disease","volume":"25","author":"Narula","year":"2010","journal-title":"J Gastroenterol Hepatol"},{"key":"R27-20230913","doi-asserted-by":"crossref","first-page":"79","DOI":"10.15403\/jgld.2014.1121.251.srw","article-title":"Probiotics in the treatment of diverticular disease. a systematic review","volume":"25","author":"Lahner","year":"2016","journal-title":"J Gastrointestin Liver Dis"},{"key":"R28-20230913","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/01.mcg.0000210092.77296.6d","article-title":"Mesalazine and\/or Lactobacillus casei in preventing recurrence of symptomatic uncomplicated diverticular disease of the colon: a prospective, randomized, open-label study","volume":"40","author":"Tursi","year":"2006","journal-title":"J Clin Gastroenterol"},{"key":"R29-20230913","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s00384-007-0299-6","article-title":"Balsalazide and\/or high-potency probiotic mixture (VSL#3) in maintaining remission after attack of acute, uncomplicated diverticulitis of the colon","volume":"22","author":"Tursi","year":"2007","journal-title":"Int J Colorectal Dis"},{"key":"R30-20230913","first-page":"916","article-title":"Mesalazine and\/or Lactobacillus casei in maintaining long-term remission of symptomatic uncomplicated diverticular disease of the colon","volume":"55","author":"Tursi","year":"2008","journal-title":"Hepatogastroenterology"},{"key":"R31-20230913","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/apt.12463","article-title":"Randomised clinical trial: mesalazine and\/or probiotics in maintaining remission of symptomatic uncomplicated diverticular disease a double-blind, randomized, placebo-controlled study","volume":"38","author":"Tursi","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"R32-20230913","first-page":"13","article-title":"Efficacy of Lactobacillus paracasei sub. paracasei F19 on abdominal symptoms in patients with symptomatic uncomplicated diverticular disease: a pilot study","volume":"57","author":"Annibale","year":"2011","journal-title":"Minerva Gastroenterol Dietol"},{"key":"R33-20230913","doi-asserted-by":"crossref","first-page":"5918","DOI":"10.3748\/wjg.v18.i41.5918","article-title":"High-fibre diet and Lactobacillus paracasei B21060 in symptomatic uncomplicated diverticular disease","volume":"18","author":"Lahner","year":"2012","journal-title":"World J Gastroenterol"},{"key":"R34-20230913","first-page":"31","article-title":"Probiotics in diverticular disease of the colon: an open label study","volume":"19","author":"Lamiki","year":"2010","journal-title":"J Gastrointestin Liver Dis"},{"key":"R35-20230913","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1177\/2050640614547068","article-title":"Italian consensus conference for colonic diverticulosis and diverticular disease","volume":"2","author":"Cuomo","year":"2014","journal-title":"United European Gastroenterol J"},{"key":"R36-20230913","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s10151-015-1370-x","article-title":"Practice parameters for the treatment of colonic diverticular disease: Italian Society of Colon and Rectal Surgery (SICCR) guidelines","volume":"19","author":"Binda","year":"2015","journal-title":"Tech Coloproctol"},{"key":"R37-20230913","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1159\/000366039","article-title":"Development and validation of an endoscopic classification of diverticular disease of the colon: the DICA classification","volume":"33","author":"Tursi","year":"2015","journal-title":"Dig Dis"}],"container-title":["Journal of Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00004836-201610001-00024","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T21:33:15Z","timestamp":1694640795000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004836-201610001-00024"}},"subtitle":["Rationale and Current Evidence"],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":37,"journal-issue":{"issue":"Supplement 1","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/mcg.0000000000000641","relation":{},"ISSN":["0192-0790"],"issn-type":[{"value":"0192-0790","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]}}}